Investing in pharma stocks: GLP-1 pills and cancer drugs in focus amid supply chain uncertainty

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the sector.
Asad Haider, Goldman Sachs Global Investment Research lead US pharmaceutical analyst and head of the healthcare business unit, joins Market Domination to discuss key trends in oncology and obesity drug developments ahead of Goldman Sachs's major healthcare conference next week.
Also, Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here: https://finance.yahoo.com/videos/series/market-domination/
#youtube #stocks #investing

About Yahoo Finance:

Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.

- Get the latest news and data at finance.yahoo.com

- Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)

- Follow Yahoo Finance on social:

X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/company/yahoo-finance

Видео Investing in pharma stocks: GLP-1 pills and cancer drugs in focus amid supply chain uncertainty канала Yahoo Finance